Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIALTO: Radiotherapy in Primarily Metastasized Prostate Cancer - Image-guided Local AbLaTion of Prostate and Oligoresidual Disease

NCT07644754 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT07644754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07644754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIALTO: Radiotherapy in Primarily Metastasized Prostate Cancer - Image-guided Local AbLaTion of Prostate and Oligoresidual Disease
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
February 28, 2031
Enrollment
27 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer metastatic disease, prostate cancer metastatic to bone